PFS (unadjusted) and OS (unadjusted) by IMWG risk criteria. (A) PFS and (B) OS were similar among IMWG high- and standard-risk patients receiving lenalidomide (Len) maintenance therapy, but poorest in high-risk patients with no maintenance therapy.